Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2011; Volume 203, Supplement 688
The 62nd National Congress of the Italian Physiological Society
9/25/2011-9/27/2011
Sorrento, Italy


CAN INTRAVITREAL RELEASE OF ACTIVE SUBSTANCES MITIGATE DAMAGE FROM OXIDATIVE STRESS IN ANIMAL MODELS OF RETINAL DEGENERATION?
Abstract number: P75

FIORANI1 L, COLECCHI1 L, PASSACANTANDO2,3 M, SANTUCCI2,3 S, BISTI1,4 S, MACCARONE1 R

1Dept of Biomedical Science and Technology, Univ. of L'Aquila, Italy
2Dept of Physic, Univ. of L'Aquila, Italy
3NANO-CAT, s.r.l., L'Aquila
4ARC Centre of Excellence in Visual Science, AU

Oxidative stress is involved in retinal degeneration induced by bright continuous light (BCL) exposure. Here we report data showing the protective effect of intravitreally released antioxidant agents (saffron extract and nanoceria-particles). The experimental protocol includes two different techniques:1) Intravitreal injection of nanoceria-particles (2ml) in the right eye 2) Elvax polymer loaded with saffron extract and inserted into the vitreal cavity of the right eye. The fellow eye was used as an internal control. Light-induced damage: after three weeks the animals were exposed to (1000 lux) light for 24h. Functional assessment: Electroretinogram (ERG) was recorded 1 week after light damage from the right and left eye. Morphological analysis: in retinal cryosectioned slices (20 mm) we measured outer nuclear layer (ONL) thickness and immunostained for inflammatory markers. Results: The ERG recorded from the right eye (injected with the CeO2) is higher compared to the left eye while in the Elvax protocol the ERG amplitude is almost comparable in both eyes. Accordingly the outer nuclear layer of the right eye is better preserved in the nanoceria experiment than in the saffron one. Our preliminary results demonstrate that while nanoparticles protect photoreceptors from light damage, maintaining both morphology and function, saffron released by Elvax doesn't present the same efficacy. The two possible ways of action are under analysis.

To cite this abstract, please use the following information:
Acta Physiologica 2011; Volume 203, Supplement 688 :P75

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE